Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 12:38 AM
NCT ID:
NCT02975167
Eligibility Criteria:
Inclusion Criteria:
* \> 18 yo
* Singleton pregnancy
* ≥ 39 weeks gestation
* Vertex presenting fetus
Exclusion Criteria:
* \< 18 years of age
* Maternal cardiac disease
* Class C diabetes mellitus or worse (as defined by the White classification system for diabetes in pregnancy)
* Gestational or chronic hypertension
* Active or history of venous thromboembolic disease requiring chemical anticoagulation
* Bleeding disorders
* History of placental abruption during current gestation
* Fetal anomalies
* Intrauterine growth restriction \< 5th percentile
* Prior uterine scar
* Vasa or placenta previa
* Active genital herpes
* Non-vertex fetal lie
* Amniotic fluid index (AFI) \< 5cm
* Multiple gestation
* (Pre)eclampsia
* Latex allergy
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02975167
Study Brief:
Protocol Section:
NCT02975167